How Artificial Intelligence Is Moving From Theoretical Promise Into Clinical Reality in Cancer Care

How Artificial Intelligence Is Moving From Theoretical Promise Into Clinical Reality in Cancer Care – SPCC

SPCC (Sharing Progress in Cancer Care) shared a post on LinkedIn:

“Meet the experts driving our upcoming discussion on the future of AI in cancer care!

On Tuesday 29 September, from 18:00 to 19:00 CEST, SPCC will host a dedicated live webinar examining how artificial intelligence is moving from theoretical promise into clinical reality.

Led by discussant Pietro Presti, MBA, PhD, this interactive session brings together two leading specialists to unpack the clinical value of AI:

Aleksandra Filipovic MD Ph.D. (Imperial College London) will present the hallmarks of artificial intelligence contributions to precision oncology.

Rebecca Romanò (Fondazione IRCCS Istituto Nazionale dei Tumori) will explore current real-world applications alongside emerging future perspectives.

The presentations will culminate in a live, interactive Q&A session where attendees can join the discussion and put their questions directly to the experts.

Participation is free of charge, but prior registration is required.

Register today to secure your place:

This session is part of the SPCC Sustaining Corporate Programme 2026. This session is part of the SPCC Sustaining Corporate Programme 2026.

Sharing Progress in Cancer Care wishes to extend appreciation to its Sustaining Companies for providing unrestricted educational support to the following webinar. Companies have no control over the session content or speakers.”

Other posts about SPCC on OncoDaily.